Nexus Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Hold
3,735
0.06% 37
2026
Q1
$449K Hold
3,735
0.06% 38
2025
Q4
$393K Hold
3,735
0.05% 37
2025
Q3
$313K Hold
3,735
0.04% 41
2025
Q2
$296K Hold
3,735
0.04% 43
2025
Q1
$482K Buy
3,735
+1,110
+42% +$104K 0.05% 41
2024
Q4
$261K Hold
2,625
0.03% 64
2024
Q3
$298K Hold
2,625
0.03% 65
2024
Q2
$325K Hold
2,625
0.03% 66
2024
Q1
$346K Hold
2,625
0.03% 66
2023
Q4
$286K Hold
2,625
0.03% 67
2023
Q3
$270K Hold
2,625
0.03% 65
2023
Q2
$303K Hold
2,625
0.03% 64
2023
Q1
$279K Hold
2,625
0.03% 65
2022
Q4
$291K Buy
+2,625
New +$268K 0.03% 66

Other funds holding MRK

Nexus Investment Management's MRK Position: Q2 2026 in Review

Nexus Investment Management held its Merck (MRK) position steady in Q2 2026 at 3,735 shares worth $480K. The position accounts for 0.06% of the portfolio, ranked #37.

Nexus Investment Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $482K in Q1 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Nexus Investment Management held 3,735 shares of Merck worth $480K as of Q2 2026.
  • Nexus Investment Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.06% of Nexus Investment Management's portfolio in Q2 2026, its #37 holding.
  • Nexus Investment Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Nexus Investment Management's Merck position peaked at $482K in Q1 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.